Table 5.
Received dose intensities
| Overall FIrB/FOx | Standard FIrB/FOx | Modified FIrB/FOx | ||||
|---|---|---|---|---|---|---|
|
Received dose intensity/cycle – mg/m2(or kg)/week | ||||||
| Median (range) | % of standard full dose | Median (range) | % of standard full dose | Median (range) | % of standard full dose | |
|
| ||||||
| Bevacizumab | 2.2 (0.2–2.5) | 88 | 2.1 (0.2–2.5) | 84 | 2.2 (1–2.5) | 88 |
| Irinotecan | 64.8 (22.4–80) | 81 | 64.9 (22.4–80) | 81 | 64.4 (36–80) | 80 |
| Oxaliplatin | 34.2 (11.4–40) | 85 | 33.1 (11.4–40) | 83 | 34.4 (20–40) | 86 |
| 5-fluorouracil | 1,465 (600–1,800) | 81 | 1,476 (600–1,800) | 82 | 1,445 (600–1,800) | 80 |